Relevance of gastrointestinal manifestations in a large Spanish cohort of patients with systemic lupus erythematosus: what do we know?

SLE can affect any part of the gastrointestinal (GI) tract. GI symptoms are reported to occur in >50% of SLE patients. To describe the GI manifestations of SLE in the RELESSER (Registry of SLE Patients of the Spanish Society of Rheumatology) cohort and to determine whether these are associated wi...

ver descrição completa

Detalhes bibliográficos
Autores: Tejera Segura, Beatriz, Altabás González, Irene, Rúa-Figueroa, Iñigo, Pérez Veiga, Natalia, Del Campo Pérez, Victor, Olivé-Marqués, Alejandro, Galindo, María, Calvo, Jaime, Ovalles-Bonilla, Juan Gabriel, Fernández-Nebro, Antonio, Menor-Almagro, Raúl, Tomero, Eva, Del Val Del Amo, Natividad, Uriarte Isacelaya, Esther, Martínez-Taboada, Víctor Manuel, Andreu, Jose L, Boteanu, Alina, Narváez, Javier, Movasat, Atusa, Montilla, Carlos, Senabre Gallego, Jose Miguel, Hernández-Cruz, Blanca, Andrés, Mariano, Salgado, Eva, Freire, Mercedes, Machín García, Sergio, Moriano, Clara, Expósito, Lorena, Pérez Velásquez, Clara, Velloso-Feijoo, M L, Cacheda, Ana Paula, Lozano-Rivas, Nuria, Bonilla, Gema, Arévalo, Marta, Jiménez, Inmaculada, Quevedo-Vila, Víctor, Manero-Ruiz, Francisco J, García de la Peña Lefebvre, Paloma, Vázquez-Rodríguez, Tomás Ramón, Ibañez-Rua, Jesús, Cobo-Ibañez, Tatiana, Pego-Reigosa, Jose María
Formato: artículo
Fecha de publicación:2021
País:España
Recursos:Universidad de Zaragoza
Repositorio:Zaguán. Repositorio Digital de la Universidad de Zaragoza
OAI Identifier:oai:zaguan.unizar.es:110876
Acesso em linha:http://zaguan.unizar.es/record/110876
Access Level:acceso abierto
id ES_ee60e9062c8bcbe8a45f9305449875a3
oai_identifier_str oai:zaguan.unizar.es:110876
network_acronym_str ES
network_name_str España
repository_id_str
spelling Relevance of gastrointestinal manifestations in a large Spanish cohort of patients with systemic lupus erythematosus: what do we know?Tejera Segura, BeatrizAltabás González, IreneRúa-Figueroa, IñigoPérez Veiga, NataliaDel Campo Pérez, VictorOlivé-Marqués, AlejandroGalindo, MaríaCalvo, JaimeOvalles-Bonilla, Juan GabrielFernández-Nebro, AntonioMenor-Almagro, RaúlTomero, EvaDel Val Del Amo, NatividadUriarte Isacelaya, EstherMartínez-Taboada, Víctor ManuelAndreu, Jose LBoteanu, AlinaNarváez, JavierMovasat, AtusaMontilla, CarlosSenabre Gallego, Jose MiguelHernández-Cruz, BlancaAndrés, MarianoSalgado, EvaFreire, MercedesMachín García, SergioMoriano, ClaraExpósito, LorenaPérez Velásquez, ClaraVelloso-Feijoo, M LCacheda, Ana PaulaLozano-Rivas, NuriaBonilla, GemaArévalo, MartaJiménez, InmaculadaQuevedo-Vila, VíctorManero-Ruiz, Francisco JGarcía de la Peña Lefebvre, PalomaVázquez-Rodríguez, Tomás RamónIbañez-Rua, JesúsCobo-Ibañez, TatianaPego-Reigosa, Jose MaríaSLE can affect any part of the gastrointestinal (GI) tract. GI symptoms are reported to occur in >50% of SLE patients. To describe the GI manifestations of SLE in the RELESSER (Registry of SLE Patients of the Spanish Society of Rheumatology) cohort and to determine whether these are associated with a more severe disease, damage accrual and a worse prognosis. METHODS: We conducted a nationwide, retrospective, multicentre, cross-sectional cohort study of 3658 SLE patients who fulfil =4 ACR-97 criteria. Data on demographics, disease characteristics, activity (SLEDAI-2K or BILAG), damage (SLICC/ACR/DI) and therapies were collected. Demographic and clinical characteristics were compared between lupus patients with and without GI damage to establish whether GI damage is associated with a more severe disease. RESULTS: From 3654 lupus patients, 3.7% developed GI damage. Patients in this group (group 1) were older, they had longer disease duration, and were more likely to have vasculitis, renal disease and serositis than patients without GI damage (group 2). Hospitalizations and mortality were significantly higher in group 1. Patients in group 1 had higher modified SDI (SLICC Damage Index). The presence of oral ulcers reduced the risk of developing damage in 33% of patients. CONCLUSION: Having GI damage is associated with a worse prognosis. Patients on a high dose of glucocorticoids are at higher risk of developing GI damage which reinforces the strategy of minimizing glucocorticoids. Oral ulcers appear to decrease the risk of GI damage. © The Author(s) 2021. Published by Oxford University Press on behalf of the British Society for Rheumatology.2021info:eu-repo/semantics/articleapplication/pdfhttp://zaguan.unizar.es/record/110876reponame:Zaguán. Repositorio Digital de la Universidad de Zaragozainstname:Universidad de ZaragozaInglésinfo:eu-repo/semantics/openAccessoai:zaguan.unizar.es:1108762026-05-29T13:59:51Z
dc.title.none.fl_str_mv Relevance of gastrointestinal manifestations in a large Spanish cohort of patients with systemic lupus erythematosus: what do we know?
title Relevance of gastrointestinal manifestations in a large Spanish cohort of patients with systemic lupus erythematosus: what do we know?
spellingShingle Relevance of gastrointestinal manifestations in a large Spanish cohort of patients with systemic lupus erythematosus: what do we know?
Tejera Segura, Beatriz
title_short Relevance of gastrointestinal manifestations in a large Spanish cohort of patients with systemic lupus erythematosus: what do we know?
title_full Relevance of gastrointestinal manifestations in a large Spanish cohort of patients with systemic lupus erythematosus: what do we know?
title_fullStr Relevance of gastrointestinal manifestations in a large Spanish cohort of patients with systemic lupus erythematosus: what do we know?
title_full_unstemmed Relevance of gastrointestinal manifestations in a large Spanish cohort of patients with systemic lupus erythematosus: what do we know?
title_sort Relevance of gastrointestinal manifestations in a large Spanish cohort of patients with systemic lupus erythematosus: what do we know?
dc.creator.none.fl_str_mv Tejera Segura, Beatriz
Altabás González, Irene
Rúa-Figueroa, Iñigo
Pérez Veiga, Natalia
Del Campo Pérez, Victor
Olivé-Marqués, Alejandro
Galindo, María
Calvo, Jaime
Ovalles-Bonilla, Juan Gabriel
Fernández-Nebro, Antonio
Menor-Almagro, Raúl
Tomero, Eva
Del Val Del Amo, Natividad
Uriarte Isacelaya, Esther
Martínez-Taboada, Víctor Manuel
Andreu, Jose L
Boteanu, Alina
Narváez, Javier
Movasat, Atusa
Montilla, Carlos
Senabre Gallego, Jose Miguel
Hernández-Cruz, Blanca
Andrés, Mariano
Salgado, Eva
Freire, Mercedes
Machín García, Sergio
Moriano, Clara
Expósito, Lorena
Pérez Velásquez, Clara
Velloso-Feijoo, M L
Cacheda, Ana Paula
Lozano-Rivas, Nuria
Bonilla, Gema
Arévalo, Marta
Jiménez, Inmaculada
Quevedo-Vila, Víctor
Manero-Ruiz, Francisco J
García de la Peña Lefebvre, Paloma
Vázquez-Rodríguez, Tomás Ramón
Ibañez-Rua, Jesús
Cobo-Ibañez, Tatiana
Pego-Reigosa, Jose María
author Tejera Segura, Beatriz
author_facet Tejera Segura, Beatriz
Altabás González, Irene
Rúa-Figueroa, Iñigo
Pérez Veiga, Natalia
Del Campo Pérez, Victor
Olivé-Marqués, Alejandro
Galindo, María
Calvo, Jaime
Ovalles-Bonilla, Juan Gabriel
Fernández-Nebro, Antonio
Menor-Almagro, Raúl
Tomero, Eva
Del Val Del Amo, Natividad
Uriarte Isacelaya, Esther
Martínez-Taboada, Víctor Manuel
Andreu, Jose L
Boteanu, Alina
Narváez, Javier
Movasat, Atusa
Montilla, Carlos
Senabre Gallego, Jose Miguel
Hernández-Cruz, Blanca
Andrés, Mariano
Salgado, Eva
Freire, Mercedes
Machín García, Sergio
Moriano, Clara
Expósito, Lorena
Pérez Velásquez, Clara
Velloso-Feijoo, M L
Cacheda, Ana Paula
Lozano-Rivas, Nuria
Bonilla, Gema
Arévalo, Marta
Jiménez, Inmaculada
Quevedo-Vila, Víctor
Manero-Ruiz, Francisco J
García de la Peña Lefebvre, Paloma
Vázquez-Rodríguez, Tomás Ramón
Ibañez-Rua, Jesús
Cobo-Ibañez, Tatiana
Pego-Reigosa, Jose María
author_role author
author2 Altabás González, Irene
Rúa-Figueroa, Iñigo
Pérez Veiga, Natalia
Del Campo Pérez, Victor
Olivé-Marqués, Alejandro
Galindo, María
Calvo, Jaime
Ovalles-Bonilla, Juan Gabriel
Fernández-Nebro, Antonio
Menor-Almagro, Raúl
Tomero, Eva
Del Val Del Amo, Natividad
Uriarte Isacelaya, Esther
Martínez-Taboada, Víctor Manuel
Andreu, Jose L
Boteanu, Alina
Narváez, Javier
Movasat, Atusa
Montilla, Carlos
Senabre Gallego, Jose Miguel
Hernández-Cruz, Blanca
Andrés, Mariano
Salgado, Eva
Freire, Mercedes
Machín García, Sergio
Moriano, Clara
Expósito, Lorena
Pérez Velásquez, Clara
Velloso-Feijoo, M L
Cacheda, Ana Paula
Lozano-Rivas, Nuria
Bonilla, Gema
Arévalo, Marta
Jiménez, Inmaculada
Quevedo-Vila, Víctor
Manero-Ruiz, Francisco J
García de la Peña Lefebvre, Paloma
Vázquez-Rodríguez, Tomás Ramón
Ibañez-Rua, Jesús
Cobo-Ibañez, Tatiana
Pego-Reigosa, Jose María
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
description SLE can affect any part of the gastrointestinal (GI) tract. GI symptoms are reported to occur in >50% of SLE patients. To describe the GI manifestations of SLE in the RELESSER (Registry of SLE Patients of the Spanish Society of Rheumatology) cohort and to determine whether these are associated with a more severe disease, damage accrual and a worse prognosis. METHODS: We conducted a nationwide, retrospective, multicentre, cross-sectional cohort study of 3658 SLE patients who fulfil =4 ACR-97 criteria. Data on demographics, disease characteristics, activity (SLEDAI-2K or BILAG), damage (SLICC/ACR/DI) and therapies were collected. Demographic and clinical characteristics were compared between lupus patients with and without GI damage to establish whether GI damage is associated with a more severe disease. RESULTS: From 3654 lupus patients, 3.7% developed GI damage. Patients in this group (group 1) were older, they had longer disease duration, and were more likely to have vasculitis, renal disease and serositis than patients without GI damage (group 2). Hospitalizations and mortality were significantly higher in group 1. Patients in group 1 had higher modified SDI (SLICC Damage Index). The presence of oral ulcers reduced the risk of developing damage in 33% of patients. CONCLUSION: Having GI damage is associated with a worse prognosis. Patients on a high dose of glucocorticoids are at higher risk of developing GI damage which reinforces the strategy of minimizing glucocorticoids. Oral ulcers appear to decrease the risk of GI damage. © The Author(s) 2021. Published by Oxford University Press on behalf of the British Society for Rheumatology.
publishDate 2021
dc.date.none.fl_str_mv 2021
dc.type.none.fl_str_mv info:eu-repo/semantics/article
format article
dc.identifier.none.fl_str_mv http://zaguan.unizar.es/record/110876
url http://zaguan.unizar.es/record/110876
dc.language.none.fl_str_mv Inglés
language_invalid_str_mv Inglés
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv
publisher.none.fl_str_mv
dc.source.none.fl_str_mv reponame:Zaguán. Repositorio Digital de la Universidad de Zaragoza
instname:Universidad de Zaragoza
instname_str Universidad de Zaragoza
reponame_str Zaguán. Repositorio Digital de la Universidad de Zaragoza
collection Zaguán. Repositorio Digital de la Universidad de Zaragoza
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1869423639858774016
score 15.301603